OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 47 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q4 2016$7,605,000,000
+715.1%
7,500,000
+650.0%
0.15%
+950.0%
Q3 2016$933,000,000
+31.6%
1,000,0000.0%0.01%
-6.7%
Q2 2016$709,000,0001,000,0000.02%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q1 2017
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 9,821,000$11,314,0001.07%
TFG Asset Management GP Ltd 6,000,000$6,883,0001.02%
Alken Asset Management Ltd 400,000$461,0000.79%
Lombard Odier Asset Management (Europe) Ltd 6,525,000$7,470,0000.54%
CSS LLC/IL 8,000,000$9,158,0000.51%
IRON Financial LLC 505,000$578,0000.28%
MACKAY SHIELDS LLC 32,796,000$37,597,0000.26%
OSTRUM ASSET MANAGEMENT 400$459,0000.22%
RWC Asset Management LLP 4,400,000$5,037,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 4,871,000$5,580,0000.16%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders